STOPit: Study of TOfacitinib for the treatment of chronic PouchITis
Latest Information Update: 22 Feb 2021
At a glance
- Drugs Tofacitinib (Primary)
- Indications Pouchitis
- Focus Therapeutic Use
- Acronyms STOPit
- Sponsors Pfizer
- 22 Feb 2021 New trial record